Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00106678 · ClinicalTrials.gov registry record
Typology of Adherence in Adolescents: Phase II
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 1,200
- Enrollment target
NCT00106678 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1,200 participants.
The verdict
NCT00106678 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 1,200 participants
- Enrollment target
Study Summary
A number of factors influence HIV-positive adolescents' acceptance of and willingness to continue taking anti-HIV medicines. These factors include mental health and substance abuse issues, barriers such as lack of medical insurance, and cognitive-behavioral barriers (such as a person's impression of the impact of the medicines on his/her health and a person's sense of his/her ability to continue taking the medications prescribed). The purpose of this study is to use a survey to determine how common specific barriers are that prevent HIV positive adolescents from taking their anti-HIV medicines and if those barriers cluster together. The information collected will be used to develop and validate a schema for classifying HIV medication adherence by barriers to adherence or clusters of barriers to adherence. This classification schema could then be used in the development of interventions that better meet the needs of HIV-infected youth.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2004-06 |
| Est. Completion | 2005-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00106678
The ClinicalTrials.gov registry entry for NCT00106678 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00106678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00106678 about?
NCT00106678 is a clinical study titled "Typology of Adherence in Adolescents: Phase II". A number of factors influence HIV-positive adolescents' acceptance of and willingness to continue taking anti-HIV medicines. These factors include mental health and substance abuse issues, barriers such as lack of medical insurance, and cognitive-behavioral barriers (such as a person's impression of...
What is the current status of trial NCT00106678?
This trial is currently completed. The enrollment target is 1,200 participants. The study started on 2004-06. Estimated completion is 2005-04.
Who is sponsoring clinical trial NCT00106678?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.